University of California Davis
Sacramento, California, 95817, United States
NCT Number: NCT06057662
The goal of this clinical trial is to learn if access to a diabetes coach improves quality of life (QOL) for families of children with newly diagnosed type 1 diabetes. The main questions it aims to answer are:
1. Determine if there are beneficial effects on diabetes-related QOL at the end of the 6-month intervention. 2. Determine if potential beneficial effects persist beyond completion of the support intervention, as measured by diabetes-related QOL at 12 months and 24 months following diagnosis
Participants assigned to the intervention group will have access to a diabetes coach for 6 months following type 1 diabetes diagnosis. They will be compared to participants who are assigned to the control group and are receiving usual care.
Interested in participating?
Request Info0 year–16 year
All sexes
Interventional
Not applicable
Sacramento, California, 95817, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
personalized comprehensive diabetes support
Time frame: 24 months
The Distress Scale (DDS) uses a 6-point Likert scale to quantify diabetes-related stress. Scores can range from 0 to 72. A higher score indicates higher distress.
Time frame: 24 months
The Problem Areas in Diabetes (PAID) uses a 6-point Likert scale to quantify diabetes-related stress. Scores can range from 0 to 100. A higher score indicates higher distress.
University of California, Davis
Other
Effect of Personalized Comprehensive Diabetes Support Among Families of Children With Newly Diagnosed Type 1 Diabetes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06420661
Autoimmune Diseases, Diabetes Mellitus
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT06300047
Autoimmune Diseases, Diabetes Mellitus
Calgary, Alberta, Canada
View Trial DetailsNCT07494188
Autoimmune Diseases, Diabetes Mellitus
Aurora, Colorado, United States
View Trial DetailsNCT06786546
Autoimmune Diseases, Cardiovascular Diseases
Austin, Texas, United States
View Trial Details